Invest
We are preclinical and raising to take LunaFlex through design verification.
Request materials
Caeruleum Biotechnologies, INC.
Caeruleum Biotechnologies, INC. is a preclinical orthopedic medical device company. The LunaFlex Meniscus is a fiber-reinforced, patient-matched synthetic meniscus, engineered to replace meniscal tissue rather than remove it.
The device
Most meniscal surgery removes tissue. LunaFlex is designed to replace it — a durable composite implant engineered to restore load distribution across the joint and to stay there for the long term.
It is being developed for the meniscus-deficient knee: patients whose meniscal tissue cannot be repaired or has already been removed, and whose remaining options are resection, allograft transplant, or waiting for a knee replacement.
The problem
Meniscal surgery is among the most common orthopaedic procedures in the U.S., and most of it removes tissue rather than restoring it.
No durable, joint-preserving option currently exists to break this cycle.
StatPearls, Knee Meniscal Tears, 2023 · Baker et al., Am J Sports Med, 1985 · National ACL Injury Coalition, 2023 · Zaffagnini et al., Arthroscopy 2019 · Sihvonen FIDELITY, NEJM · Roos et al., Arthritis Rheum 1998.
Work with us
We are preclinical and raising to take LunaFlex through design verification.
Request materialsFor corporate and business development teams weighing meniscal replacement as a category.
Start a conversationWe are recruiting orthopaedic surgeons to a clinical advisory board.
Express interest